ASCO Includes MammaPrint Assay in Breast Cancer Guideline Updates
The American Society of Clinical Oncology updated its guidelines to include the 70-gene MammaPrint assay to direct decisions for some patients with breast cancer.
The American Society of Clinical Oncology updated its guidelines to include the 70-gene MammaPrint assay to direct decisions for some patients with breast cancer.
Three years of adjuvant imatinib therapy results in longer survival than 1 year of imatinib in high-risk gastrointestinal stromal tumors (GISTs).
Nanoparticle drug delivery may revolutionize the way patients with cancer receive treatment, but the technology is still in its infancy.
Recent news has brought attention to HPV and its connection to cancer, but there is still confusion about how and when the vaccine should be given.
The unmet need for highly targeted, less toxic lung cancer therapies may be met with the use of biologics.
Women who experience a significant weight change following a diagnosis with breast cancer, and who also have comorbidities, experience poor survival.
Infection with specific subtypes of human papillomavirus (HPV) is a risk factor for squamous cell carcinoma (SCC) of the skin.
Different survival rates between US Asian residents and other ethnicities reflect health care disparities.
Endoscopists can accurately predict histology of polyps without resection by using narrow band imaging (NBI).
New data from the phase 3 EMILIA study demonstrated that trastuzumab emtansine (T-DM1) significantly improves survival in patients with human estrogen receptor 2 (HER2)-positive metastatic breast cancer.